Skip to main content
. 2018 May 1;11(5):2749–2758.

Table 4.

Univariate analyses of overall survival (OS) time

Variable n Mean OS (months) Log-rank P value
VM 56.100 <0.001
    Negative 125 41.9±20.4
    Positive 73 22.3±13.3
Slug 25.376 <0.001
    Negative 54 47.2±20.6
    Positive 144 30.0±18.3
Vimentin 61.383 <0.001
    Negative 131 41.4±19.8
    Positive 67 21.6±14.4
Age (years) 11.645 0.001
    <60 64 40.9±23.4
    ≥60 134 31.7±18.2
Gender 0.994 0.319
    Female 52 37.2±21.4
    Male 146 33.8±20.1
Smoking 1.658 0.198
    No 80 37.8±20.7
    Yes 118 32.5±20.0
Size (cm) 24.638 <0.001
    <3.0 36 43.5±20.6
    ≥3.0, <7.0 130 35.1±20.6
    ≥7.0 32 22.9±13.2
Gross Type 0.001 0.975
    Central 107 33.9±19.8
    Peripheral 91 35.5±21.1
Histological Type 0.066 0.797
    Squamous cell carcinoma 105 35.4±20.5
    Adenocarcinoma 93 33.9±20.4
Grade 11.513 0.003
    Well 38 42.2±20.4
    Moderate 128 34.6±20.5
    Poor 32 26.3±17.1
LNM 79.942 <0.001
    N0 84 47.2±19.0
    N1 86 27.6±17.5
    N2 28 18.8±7.7
TNM stage 82.953 <0.001
    I + II 81 49.5±18.5
    III + IV 117 24.4±14.6